AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new policy for commercial coverage of its cfDNA Fetal ...
AUSTIN, Texas, February 03, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new policy for commercial coverage ...
Natera (NTRA), announced a new policy for commercial coverage of its cfDNA Fetal RhD noninvasive prenatal test, Fetal RhD NIPT from one of the largest payors in the United States. Effective as of ...
Coverage from one of the largest payors in the country expands access to fetal RhD testing for pregnant patients nationwide Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA ...
AUSTIN, Texas, January 15, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, today, at the 43rd ...
Leerink Partners analyst Puneet Souda has maintained their bullish stance on NTRA stock, giving a Buy rating yesterday. Puneet Souda has given his Buy rating due to a combination of factors that ...
Natera NTRA underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a concise overview of recent ratings by ...
In addition, you can check the fund’s top 5 holdings to determine its best picks for 2024. Alger Small Cap Growth Fund highlighted stocks like Natera, Inc. (NASDAQ:NTRA), in the fourth quarter 2024 ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, today, at the 43rd annual J.P. Morgan Healthcare Conference. In addition ...
Sharon Raj murder case: Greeshma's act of inviting Sharon over under the pretext of sexual intimacy and committing the crime cannot be ignored, the court said. Sharon Raj murder case: A district ...